( 02256.hk)
市盈率129.24市净率3.71股息率0%上市时间2021-10-13股价10.97港币涨跌幅2.14%成交金额2,124.40万港币换手率0.26%市值79.45亿港币H股市值79.45亿港币总股本7.24亿H股本7.24亿每手股数1,000上市至今年化投资收益率-2.45%累计做空占H股比例2.13% (1.77亿港币2026-07-03)
所属三级行业生物技术 (恒生) 市盈率120.34市净率4.39股息率0.38%恒生:医疗保健业药品及生物科技生物技术
备注 (4): 双击编辑备注
发表讨论

和誉-B(02256) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1孫洪斌Independent Non Executive Director - A/F2021-09-30--
2孫飄揚Independent Non Executive Director2021-09-30--
3王磊Independent Non Executive Director2021-09-30--
4唐豔旻Non Executive Director2021-06-10--
5葉霖Executive Director2021-01-052022-04-28
6XIA Guo Yao GavinNon Executive Director2018-10-222023-06-19
7CHEN ZhuiExecutive Director2018-03-28--
8XU Yao ChangExecutive Director2018-03-28--
9YU Hong PingExecutive Director2018-03-28--